Position in QGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Jun 30, 2026CallValue
$1,564,000
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $3,725,083 across 4 Diagnostics & Research names.
All Filings in QGEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,564,000 | 40,000 | Call | Sole | 2026-08-13 | |
| 2026-03-31 | $2,002,000 | 50,000 | Put | Sole | 2026-05-14 | |
| 2026-03-31 | $2,002,000 | 50,000 | Call | Sole | 2026-05-14 | |
| 2024-09-30 | $477,938 | 10,488 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $473,397 | 11,521 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $775,023 | 18,028 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $420,243 | 8,866 | Shares | Other | 2023-05-15 | |
| 2022-03-31 | $397,360 | 7,858 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $1,682,675 | 31,200 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $6,471,828 | 120,000 | Put | Sole | 2020-11-16 | |
| 2020-06-30 | $390,724 | 8,844 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||